Dehydronandrolon Powder (2590-41-2) video

Dehydronandrolon Powder (2590-41-2) Specification:

Dehydronandrolon Powder (2590-41-2) Description:

Dehydronandrolon acetate is a key intermediate for the synthesis (faslodex) , while the former was an anti-breast-cancer drug developed and the latter was a synthetic steroid marketed for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.

Reference:

• Benign Prostatic Hypertrophy. Springer Science & Business Media. 6 December 2012. pp. 277–. ISBN 978-1-4612-5476-8.
• Achim Jörres (19 February 2010). Management of Acute Kidney Problems. Springer. p. 210. ISBN 978-3-540-69413-7. Retrieved 27 May 2012.
• Yang YQ, Li SX, Gu XG (August 1985). “[Effect of progestin no. 1 (cymegesolate) on menstrual cycles and plasma levels of progesterone in rhesus monkeys]”. Sheng Li Xue Bao (in Chinese). 37 (4): 368–73. PMID 3837333.